arrow
F

Felix K.-H. Chun

Goethe University Frankfurt
H指数:70
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer

对偶然性前列腺癌中新型风险分层模型与当前cT1a/b分期的比较

2026-09-290
PRE
Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States

美国前列腺特异性膜抗原正电子发射断层扫描时代转移性前列腺癌的流行趋势

2026-09-290
OAAI
Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma

邻近器官侵犯对非转移性肾细胞癌特异性死亡率的影响

2026-07-200
OAAI
Structured Feedback Tools in Surgical Training: Results of the Endo-Workshop of the German Society of Residents in Urology 2024

外科培训中的结构化反馈工具:德国泌尿外科住院医师学会2024年内镜工作坊结果

2026-01-010
PRE
The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria

根据纳入标准的部分膀胱切除术中盆腔淋巴结清扫对癌症特异性死亡率的影响

2025-12-030
PRE
Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

机器人辅助与开放性部分细胞减灭术肾切除术在转移性肾细胞癌中的院内不良结局比较

2025-11-110
OAAI
Inflammatory bowel disease vs. adverse in-hospital outcomes after radical prostatectomy

炎症性肠病与根治性前列腺切除术后的院内不良结局比较

2025-11-010
PRE
Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D'amico Risk Groups in A Contemporary Cohort

根据年龄和D'amico风险组,当代队列中前列腺癌外照射放疗后继发性膀胱和直肠癌的发生率

2025-11-012
PRE
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma
2025-11-010
PRE
Cancer-specific mortality in secondary bladder cancer after nephroureterectomy for upper tract urothelial carcinoma
2025-11-010
OAAI
Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy

截瘫患者接受根治性前列腺切除术的院内不良结局

2025-10-100
OAAI
Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patients

新辅助化疗对接受根治性膀胱切除术治疗的T2N0M0膀胱癌患者寿命损失年的影响

2025-10-040
PRE
Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma

围手术期放疗及非转移性腹膜后肉瘤外科治疗后的生存情况

2025-10-010
PRE
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological Subtypes

肾细胞癌伴肿瘤栓子行根治性肾切除术和血栓切除术后的癌症特异性死亡率:按组织学亚型

2025-09-240
PRE
177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study

177Lu-PSMA 与 cabazitaxel 在去势抵抗性前列腺癌患者中的真实世界疗效与安全性数据:ARON-3 研究结果

2025-09-120
PREAI
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate Cancer

USPSTF建议反对PSA筛查与局限性前列腺癌的分期及癌症特异性死亡率

2025-09-090
PRE
ASO Visual Abstract: The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary Diversion

ASO视觉摘要:慢性肝病对根治性膀胱切除术和回肠导管尿流改道术后院内不良预后的影响

2025-09-060
PRE